Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.

Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL
Minerva Anestesiol 2010;76(8):584-591.
NATA Rating :
Review by : K. Holte
NATA Review

Albumin versus various colloids including several HES preparations has been evaluated in many recent trials in cardiopulmonary bypass. This trial, reporting no difference between albumin and HES 130/0.4 on coagulation variables, blood loss and immunological activity does not add any new information to the body of evidence already present in the area.

– Kathrine Holte

Consent Management Platform by Real Cookie Banner